Migraine and biomarkers of cardiovascular disease in women

Cephalalgia

Volumn 28, Issue 1, 2008, Pages 49-56

  Kurth, T ^a,b   Ridker, P M ^a,b   Buring, J E ^a,b,c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Cardiovascular disease; Epidemiology; Migraine; Women

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B100; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CHOLESTEROL; CREATININE; FIBRINOGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; INTERCELLULAR ADHESION MOLECULE 1; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AMINO ACID BLOOD LEVEL; ARTICLE; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CONFIDENCE INTERVAL; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; FEMALE; FIBRINOGEN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MIGRAINE AURA; MIGRAINE WITH AURA; PROTEIN BLOOD LEVEL;

BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CHOLESTEROL; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MIDDLE AGED; MIGRAINE DISORDERS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 36749095223     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1111/j.1468-2982.2007.01467.x     Document Type: Article

References (33)

1. Lipton RB, Bigal ME. The epidemiology of migraine. Am J Med 2005 118 (Suppl. 1 3S 10S.
2. Etminan M, Takkouche B, Isorna FC, Samii A. Risk of ischaemic stroke in people with migraine: systematic review and meta-analysis of observational studies. BMJ 2005 330 : 63 5.
3. Kruit MC, van Buchem MA, Hofman PA, Bakkers JT, Terwindt GM, Ferrari MD, Launer LJ. Migraine as a risk factor for subclinical brain lesions. JAMA 2004 291 : 427 34.
4. Kruit MC, Launer LJ, Ferrari MD, van Buchem MA. Infarcts in the posterior circulation territory in migraine. The population-based MRI CAMERA study. Brain 2005 128 : 2068 77.
5. Kurth T, Slomke MA, Kase CS, Cook NR, Lee IM, Gaziano JM et al. Migraine, headache, and the risk of stroke in women: a prospective study. Neurology 2005 64 : 1020 6.
6. Stang PE, Carson AP, Rose KM, Mo J, Ephross SA, Shahar E, Szklo M. Headache, cerebrovascular symptoms, and stroke: the Atherosclerosis Risk in Communities Study. Neurology 2005 64 : 1573 7.
7. Kurth T, Gaziano JM, Cook NR, Logroscino G, Diener HC, Buring JE. Migraine and risk of cardiovascular disease in women. JAMA 2006 296 : 283 91.
8. Scher AI, Terwindt GM, Picavet HS, Verschuren WM, Ferrari MD, Launer LJ. Cardiovascular risk factors and migraine: the GEM population-based study. Neurology 2005 64 : 614 20.
9. Hering-Hanit R, Friedman Z, Schlesinger I, Ellis M. Evidence for activation of the coagulation system in migraine with aura. Cephalalgia 2001 21 : 137 9.
10. Soriani S, Borgna-Pignatti C, Trabetti E, Casartelli A, Montagna P, Pignatti PF. Frequency of factor V Leiden in juvenile migraine with aura. Headache 1998 38 : 779 81.
11. Ferrari MD, Odink J, Tapparelli C, Van Kempen GM, Pennings EJ, Bruyn GW. Serotonin metabolism in migraine. Neurology 1989 39 : 1239 42.
12. Lea RA, Ovcaric M, Sundholm J, Macmillan J, Griffiths LR. Genetic variants of angiotensin converting enzyme and methylenetetrahydrofolate reductase may act in combination to increase migraine susceptibility. Brain Res Mol Brain Res 2005 136 : 112 17.
13. Scher AI, Terwindt GM, Verschuren WM, Kruit MC, Blom HJ, Kowa H et al. Migraine and MTHFR C677T genotype in a population-based sample. Ann Neurol 2006 59 : 372 5.
14. Kowa H, Yasui K, Takeshima T, Urakami K, Sakai F, Nakashima K. The homozygous C677T mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for migraine. Am J Med Genet 2000 96 : 762 4.
15. Lea RA, Ovcaric M, Sundholm J, MacMillan J, Grifflths LR. The methylenetetrahydrofolate reductase gene variant C677T influences susceptibility to migraine with aura. BMC Med 2004 2 : 3.
16. Rexrode KM, Lee IM, Cook NR, Hennekens CH, Buring JE. Baseline characteristics of participants in the Women's Health Study. J Womens Health Gend Based Med 2000 9 : 19 27.
17. Ridker PM, Cook NR, Lee IM, Gordon D, Gaziano JM, Manson JE et al. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med 2005 352 : 1293 304.
18. Lee IM, Cook NR, Gaziano JM, Gordon D, Ridker PM, Manson JE et al. Vitamin E in the primary prevention of cardiovascular disease and cancer: the Women's Health Study: a randomized controlled trial. JAMA 2005 294 : 56 65.
19. Bensenor IM, Cook NR, Lee IM, Chown MJ, Hennekens CH, Buring JE. Low-dose aspirin for migraine prophylaxis in women. Cephalalgia 2001 21 : 175 83.
20. Cook NR, Bensenor IM, Lotufo PA, Lee IM, Skerrett PJ, Chown MJ et al. Migraine and coronary heart disease in women and men. Headache 2002 42 : 715 27.
21. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders cranial neuralgias and facial pain. Cephalalgia 1988 8 : 1 96.
22. Hanline A, Karon J, Lippel K. Manual of laboratory operations. Lipid research clinics program and lipid and lipoprotein analysis, 2nd edn. Bethesda, MD : US Department of Health and Human Services, 1982.
23. Waeber C, Moskowitz MA. Migraine as an inflammatory disorder. Neurology 2005 64 : S9 15.
24. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 2002 347 : 1557 65.
25. Welch KM, Brandes AW, Salerno L, Brandes JL. C-reactive protein may be increased in migraine patients who present with complex clinical features. Headache 2006 46 : 197 9.
26. Bianchi A, Pitari G, Amenta V, Giuliano F, Gallina M, Costa R, Ferlito S. Endothelial, haemostatic and haemorheological modifications in migraineurs. Artery 1996 22 : 93 100.
27. Martelletti P, Stirparo G, Morrone S, Rinaldi C, Giacovazzo M. Inhibition of intercellular adhesion molecule-1 (ICAM-1), soluble ICAM-1 and interleukin-4 by nitric oxide expression in migraine patients. J Mol Med 1997 75 : 448 53.
28. de Bree A, Verschuren WM, Bjorke-Monsen AL, van der Put NM, Heil SG, Trijbels FJ, Blom HJ. Effect of the methylenetetrahydrofolate reductase 677C→T mutation on the relations among folate intake and plasma folate and homocysteine concentrations in a general population sample. Am J Clin Nutr 2003 77 : 687 93.
29. Hering-Hanit R, Gadoth N, Yavetz A, Gavendo S, Sela B. Is blood homocysteine elevated in migraine? Headache 2001 41 : 779 81.
30. Tietjen GE, Al-Qasmi MM, Athanas K, Dafer RM, Khuder SA. Increased von Willebrand factor in migraine. Neurology 2001 57 : 334 6.
31. Gallai V, Sarchielli P, Firenze C, Trequattrinl A, Paciaroni M, Usai F, Palumbo R. Endothelin 1 in migraine and tension-type headache. Acta Neurol Scand 1994 89 : 47 55.
32. Lipton RB, Stewart WF, Diamond S, Diamond ML, Reed M. Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache 2001 41 : 646 57.
33. Launer LJ, Terwindt GM, Ferrari MD. The prevalence and characteristics of migraine in a population-based cohort: the GEM study. Neurology 1999 53 : 537 42.